435 related articles for article (PubMed ID: 19840668)
41. TMPRSS2 Independency for Haemagglutinin Cleavage In Vivo Differentiates Influenza B Virus from Influenza A Virus.
Sakai K; Ami Y; Nakajima N; Nakajima K; Kitazawa M; Anraku M; Takayama I; Sangsriratanakul N; Komura M; Sato Y; Asanuma H; Takashita E; Komase K; Takehara K; Tashiro M; Hasegawa H; Odagiri T; Takeda M
Sci Rep; 2016 Jul; 6():29430. PubMed ID: 27389476
[TBL] [Abstract][Full Text] [Related]
42. [The role of cleavage activation of the hemagglutinin by host and bacterial proteases in the induction of the pathogenesis of influenza viruses].
Tashiro M
Nihon Rinsho; 1997 Oct; 55(10):2633-9. PubMed ID: 9360383
[TBL] [Abstract][Full Text] [Related]
43. Identification of trypsin I as a candidate for influenza A virus and Sendai virus envelope glycoprotein processing protease in rat brain.
Le TQ; Kawachi M; Yamada H; Shiota M; Okumura Y; Kido H
Biol Chem; 2006 Apr; 387(4):467-75. PubMed ID: 16606346
[TBL] [Abstract][Full Text] [Related]
44. Generation and characterization of reassortant influenza A viruses propagated in serum-free cultured MDCK-SF1 cells.
Voeten JT; Claas EC; Brands R; Palache AM; van Scharrenburg GJ; Rimmelzwaan GF; Osterhaus AD
Dev Biol Stand; 1999; 98():77-87; discussion 89-90. PubMed ID: 10494961
[TBL] [Abstract][Full Text] [Related]
45. TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice.
Tarnow C; Engels G; Arendt A; Schwalm F; Sediri H; Preuss A; Nelson PS; Garten W; Klenk HD; Gabriel G; Böttcher-Friebertshäuser E
J Virol; 2014 May; 88(9):4744-51. PubMed ID: 24522916
[TBL] [Abstract][Full Text] [Related]
46. The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells.
Yamaya M; Shimotai Y; Hatachi Y; Lusamba Kalonji N; Tando Y; Kitajima Y; Matsuo K; Kubo H; Nagatomi R; Hongo S; Homma M; Nishimura H
Pulm Pharmacol Ther; 2015 Aug; 33():66-74. PubMed ID: 26166259
[TBL] [Abstract][Full Text] [Related]
47. Use of MDCK cells for production of live attenuated influenza vaccine.
Liu J; Shi X; Schwartz R; Kemble G
Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
[TBL] [Abstract][Full Text] [Related]
48. Activation of influenza A viruses by host proteases from swine airway epithelium.
Peitsch C; Klenk HD; Garten W; Böttcher-Friebertshäuser E
J Virol; 2014 Jan; 88(1):282-91. PubMed ID: 24155384
[TBL] [Abstract][Full Text] [Related]
49. Heterogeneity of the MDCK cell line and its applicability for influenza virus research.
Lugovtsev VY; Melnyk D; Weir JP
PLoS One; 2013; 8(9):e75014. PubMed ID: 24058646
[TBL] [Abstract][Full Text] [Related]
50. Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture.
Genzel Y; Behrendt I; König S; Sann H; Reichl U
Vaccine; 2004 Jun; 22(17-18):2202-8. PubMed ID: 15149778
[TBL] [Abstract][Full Text] [Related]
51. Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium.
Böttcher-Friebertshäuser E; Klenk HD; Garten W
Pathog Dis; 2013 Nov; 69(2):87-100. PubMed ID: 23821437
[TBL] [Abstract][Full Text] [Related]
52. Plasminogen promotes influenza A virus replication through an annexin 2-dependent pathway in the absence of neuraminidase.
LeBouder F; Lina B; Rimmelzwaan GF; Riteau B
J Gen Virol; 2010 Nov; 91(Pt 11):2753-61. PubMed ID: 20702651
[TBL] [Abstract][Full Text] [Related]
53. The growth of attenuated influenza vaccine donor strains in continuous cell lines.
Audsley JM; Tannock GA
J Virol Methods; 2005 Feb; 123(2):187-93. PubMed ID: 15620401
[TBL] [Abstract][Full Text] [Related]
54. Development of substrate analogue inhibitors for the human airway trypsin-like protease HAT.
Sielaff F; Böttcher-Friebertshäuser E; Meyer D; Saupe SM; Volk IM; Garten W; Steinmetzer T
Bioorg Med Chem Lett; 2011 Aug; 21(16):4860-4. PubMed ID: 21741839
[TBL] [Abstract][Full Text] [Related]
55. High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases.
Smith KA; Colvin CJ; Weber PS; Spatz SJ; Coussens PM
Vaccine; 2008 Jul; 26(29-30):3778-82. PubMed ID: 18524432
[TBL] [Abstract][Full Text] [Related]
56. Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines.
van Wielink R; Kant-Eenbergen HC; Harmsen MM; Martens DE; Wijffels RH; Coco-Martin JM
J Virol Methods; 2011 Jan; 171(1):53-60. PubMed ID: 20933017
[TBL] [Abstract][Full Text] [Related]
57. The Hemagglutinin of Bat-Associated Influenza Viruses Is Activated by TMPRSS2 for pH-Dependent Entry into Bat but Not Human Cells.
Hoffmann M; Krüger N; Zmora P; Wrensch F; Herrler G; Pöhlmann S
PLoS One; 2016; 11(3):e0152134. PubMed ID: 27028521
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of proteolytic cleavage of the hemagglutinin of influenza virus by the calcium-specific ionophore A23187.
Klenk HD; Garten W; Rott R
EMBO J; 1984 Dec; 3(12):2911-5. PubMed ID: 6441705
[TBL] [Abstract][Full Text] [Related]
59. Enterokinase Enhances Influenza A Virus Infection by Activating Trypsinogen in Human Cell Lines.
Hayashi H; Kubo Y; Izumida M; Takahashi E; Kido H; Sato K; Yamaya M; Nishimura H; Nakayama K; Matsuyama T
Front Cell Infect Microbiol; 2018; 8():91. PubMed ID: 29629340
[TBL] [Abstract][Full Text] [Related]
60. Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics.
Cross KJ; Wharton SA; Skehel JJ; Wiley DC; Steinhauer DA
EMBO J; 2001 Aug; 20(16):4432-42. PubMed ID: 11500371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
